angustmycin a has been researched along with hesperetin in 1 studies
Studies (angustmycin a) | Trials (angustmycin a) | Recent Studies (post-2010) (angustmycin a) | Studies (hesperetin) | Trials (hesperetin) | Recent Studies (post-2010) (hesperetin) |
---|---|---|---|---|---|
44 | 0 | 7 | 585 | 15 | 417 |
Protein | Taxonomy | angustmycin a (IC50) | hesperetin (IC50) |
---|---|---|---|
Cytochrome P450 1A1 | Homo sapiens (human) | 2.786 | |
Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | 8.3 | |
Dipeptidyl peptidase 4 | Homo sapiens (human) | 0.28 | |
Cytochrome P450 1B1 | Homo sapiens (human) | 0.511 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
1 other study(ies) available for angustmycin a and hesperetin
Article | Year |
---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |